# An Intestinal Melanoma of Unknown Origin Presenting as an Intussusception: A Case Report of a Rare Entity

**Authors:** Diego Ontiveros Ramírez, Carlos Alberto Ramírez Alvarado, Mario Alberto Ramírez Gonzalez, Fernando Carballar Mejía, Sergio Maldonado Mares

PMC · DOI: 10.7759/cureus.80032 · Cureus · 2025-03-04

## TL;DR

A rare case of intestinal melanoma presenting as intestinal blockage is reported, highlighting the difficulty in diagnosing and treating this aggressive cancer.

## Contribution

This case report adds to the limited literature on gastrointestinal melanoma and emphasizes the need for improved treatment strategies.

## Key findings

- The patient had metastatic melanoma in the small intestine, confirmed by histopathology and specific markers.
- Surgery was the primary treatment, but systemic therapies remain underdeveloped for this aggressive cancer.
- The case underscores the importance of considering rare cancers in patients with unexplained abdominal symptoms.

## Abstract

Melanoma involving the gastrointestinal (GI) tract is an exceedingly rare and clinically challenging entity, often presenting with nonspecific symptoms that can delay diagnosis and treatment. This report describes the case of a 74-year-old male with a history of melanoma of unknown primary origin who presented with acute intestinal obstruction secondary to metastatic melanoma in the small intestine. The patient’s clinical course was complicated by intermittent subocclusion, anemia, and hemodynamic instability, culminating in exploratory laparotomy and resection of the affected intestinal segment. Histopathological examination confirmed metastatic melanoma, positive for SOX10, HMB45, and Ki67 markers. This case highlights the diagnostic and therapeutic challenges of GI melanoma, emphasizing the importance of considering rare malignancies in patients with atypical abdominal symptoms, particularly those with a history of melanoma. The discussion underscores the aggressive nature of GI melanoma, the role of surgery as the primary treatment modality, and the need for further research into systemic therapies to improve outcomes in this patient population.

## Linked entities

- **Proteins:** SOX10 (SRY-box transcription factor 10), PMEL (premelanosome protein), Mki67 (antigen identified by monoclonal antibody Ki 67)
- **Diseases:** melanoma (MONDO:0005105), gastrointestinal melanoma (MONDO:0045070), anemia (MONDO:0002280), intestinal obstruction (MONDO:0004565)

## Full-text entities

- **Genes:** SOX10 (SRY-box transcription factor 10) [NCBI Gene 6663] {aka DOM, PCWH, SOX-10, WS2E, WS4, WS4C}
- **Diseases:** GI melanoma (MESH:D008545), acute intestinal obstruction (MESH:D007415), Intussusception (MESH:D007443), malignancies (MESH:D009369), anemia (MESH:D000740)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11967775/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11967775/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC11967775/full.md

---
Source: https://tomesphere.com/paper/PMC11967775